Experimental treatments could help U.S. Ebola patient
There are no vaccines or known drugs specifically approved to treat the rare Bundibugyo strain of Ebola in the Democratic Republic of Congo.
Search fresh public links, source activity, and post angles for Experimental Treatment.
Fresh curated links around Experimental treatment are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
There are no vaccines or known drugs specifically approved to treat the rare Bundibugyo strain of Ebola in the Democratic Republic of Congo.
"CBS Saturday Morning" looks at an experimental treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, that is bringing hope to some patients suffering from the neur...
The first participant has been dosed in a Phase 1 clinical trial testing TNV262, an experimental therapy that Tenvie Therapeutics is developing as a potential treatment for multipl...
The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is remarkable for a paralyzing, usually fatal disease.
In a monumental leap forward for tuberculosis treatment, a groundbreaking combination therapy known as Alpibectir–Ethionamide, abbreviated as AlpE, has been unveiled by an internat...
The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including ‌Mapp Biopharmaceutical's MBP134, Regeneron's m...
In a groundbreaking advancement poised to transform the management of degenerative joint diseases, researchers have unveiled the first-in-human, multicenter phase I clinical trial...
Stephen Allan was among patients around the UK given the chance to trial the new medication after he suffered complications to his treatment.
Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. I...
When ICUs filled up during the COVID-19 pandemic, Ottawa scientists rushed to develop an experimental treatment. Sharon Charlebois says it saved her life.
In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
In a groundbreaking stride against one of oncology’s most formidable challenges, researchers have unveiled promising clinical trial results exploring novel immunotherapeutic strate...
Ukko has dosed the first participant in a Phase 1/2a trial of its experimental peanut allergy therapy, UKK-0018. The post Ukko Launches Early Human Study of Precision Peanut Allerg...
Israeli scientists developed a modified peanut that showed promising results in treating children with severe peanut allergies. The post Researchers Develop Novel Treatment by Unfo...
Research has shown early diagnosis and treatment of epilepsy disorders can improve outcomes. The question of when to administer treatment so it gets ahead of the disease, however,...
Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It didn’t always work.
A patient in Nijmegen has become the first person in the world to receive a new form of genetic treatment...
The UK Health Security Agency has accepted delivery of Favipiravir, which remains experimental for use to treat hantavirus.
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.
OH HAPPY DAY – May 21, 2026 – An existing drug primarily used to treat rheumatoid arthritis could offer a significant new treatment avenue for individuals battling difficult-to-tre...
This clinical trial was just registered: Morton's Neuroma: Manipulation Versus Steroid Injection The aim of this study is to establish which of two treatment options i...
Applying data from clinical trials is intrinsically problematic because the benefits of an intervention are presented as group averages and do not describe how an individual patien...
Russia has administered the first personalized vaccine to a clinical patient, a man with stage three skin cancer Read Full Article at RT.com
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.